JAMA study: DES benefits outweigh risks

Pedersen, Amanda
July 2008
Cardiovascular Devices & Drugs;Jul2008, Vol. 14 Issue 7, p26
The article reports on a study on drug-eluting stents (DES) which appeared in the "Journal of the American Medical Association (JAMA)." The results of the study has shed some positive light on the DES which have been linked to an increased risk of stent thrombosis. The study indicates that the use of DES leads to a decrease in the need for repeat procedures to unblock coronary arteries without an increased risk of death. Doctor Howard Herrmann stresses that the benefits of DES such as a decreased risk for restenosis outweigh its risks.


Related Articles

  • Death rates higher with drug-eluting than bare metal stents.  // Reactions Weekly;4/4/2009, Issue 1246, p4 

    The article discusses a study which examined death rates associated with drug eluting and bare metal stents. Autopsy cases from the CVPath registry of coronary arteries were reviewed in the study. Findings showed that stent-related death was higher with use of drug-eluting stents. Thrombosis and...

  • The role of coronary artery stents in PCI. Muggenthaler, Martina; Singh, Amar; Wilkinson, Peter // British Journal of Cardiac Nursing;Jan2008, Vol. 3 Issue 1, p24 

    Coronary artery stents are small expandable mesh devices inserted into the coronary arteries as a means to improve the blood flow where a stenosis is seen on angiography. Recent advances in stent technology have included the use of drugs released from the stents themselves (known as drug-eluting...

  • Evaluation of the effect of stent strut profile on shear stress distribution using statistical moments. Mejia, Juan; Ruzzeh, Bilal; Mongrain, Rosaire; Leask, Richard; Bertrand, Olivier F. // BioMedical Engineering OnLine;2009, Vol. 8, Special section p1 

    Background: In-stent restenosis rates have been closely linked to the wall shear stress distribution within a stented arterial segment, which in turn is a function of stent design. Unfortunately, evaluation of hemodynamic performance can only be evaluated with long term clinical trials. In this...

  • Increased Platelet Indices in Acute Stent Thrombosis. Cetin, Mustafa; Balli, Mehmet; Tasolar, Hakan; Cakici, Musa; Bakirci, Eftal Murat // Angiology;Sep2014, Vol. 65 Issue 8, p745 

    A response from the author of the article "Increased platelet distribution width is associated with st-segment elevation myocardial infarction and thrombolysis failure" in 2014 issue is presented.

  • The Influence of Strut-Connectors in Stented Vessels: A Comparison of Pulsatile Flow Through Five Coronary Stents. PANT, SANJAY; BRESSLOFF, NEIL W.; FORRESTER, ALEXANDER I. J.; CURZEN, NICK // Annals of Biomedical Engineering;May2010, Vol. 38 Issue 5, p1893 

    The design of coronary stents has evolved significantly over the past two decades. However, they still face the problem of in-stent restenosis, formation of neointima within 12 months of the implant. The biological response after stent implantation depends on various factors including the stent...

  • Untitled.  // Medical Device Daily;3/27/2009, Vol. 13 Issue 58, p10 

    The article reports on the development of Terumo Medical's Nobori Core drug-eluting stent (DES). The stent was compared to Cordis' Cypher in a non-randomized study that involved 54 patients treated with the Nobori Core and 53 treated with Cypher with data released in 2007. Based on a nine-month...

  • Global Therapeutics uses best of DES, BMS for stent.  // Medical Technology & Devices Week;8/20/2007, Vol. 5 Issue 34, p2 

    The article reports on the integration of the drug-eluting stent and bare metal stent technologies by Global Therapeutics. With the integration, the company was able to create a new stent system that employs a follow-on an antisense agent, developed by AVI BioPharma, to arrest the process of...

  • HTAC Report on Intracoronary Brachytherapy. Preboth, Monica // American Family Physician;11/1/2001, Vol. 64 Issue 9, p1639 

    Reports on the publication of a report on intracoronary brachytherapy by the Health Technology and Advisory Committee. Purpose of the report to help physicians learn how safe the procedure is, whether catheter-based gamma- or beta-radiation can effectively reduce restenosis rates after...

  • Predictive Factors of In-Stent Restenosis in Renal Artery Stenting: A Retrospective Analysis. Vignali, Claudio; Bargellini, Irene; Lazzereschi, Michele; Cioni, Roberto; Petruzzi, Pasquale; Caramella, Davide; Pinto, Stefania; Napoli, Vinicio; Zampa, Virna; Bartolozzi, Carlo // CardioVascular & Interventional Radiology;May2005, Vol. 28 Issue 3, p296 

    Purpose: To retrospectively evaluate the role of clinical and procedural factors in predicting in-stent restenosis in patients with renovascular disease treated by renal artery stenting. Methods: From 1995 to 2002, 147patient s underwent renal artery stenting for the treatment of significant...

  • Drug-eluting stents not warranted for all patients.  // PharmacoEconomics & Outcomes News;10/8/2005, Issue 488, p5 

    Suggests that drug-eluting stents do not appear to be cost effective compared with bare-metal stents for the prevention of coronary artery restenosis in patients undergoing percutaneous coronary intervention, according to a clinical report published in the September 10, 2005 issue of the journal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics